Promotion of microtubule assembly in vitro by taxol
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PTX is a member of taxanes family, which arrest cells in the G2/M phase by binding to the β-tubulin subunits, inhibiting depolymerization of microtubules and cause apoptosis through cell-signaling cascades [3].”
In the citing paper
“The binding of paclitaxel counters the conformational effect of GTP-hydrolysis on microtubules, stabilizing microtubules against depolymerization.69,70”
From Electronic energy migration in microtubules (2023) · cites this paper as [69]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Microtubule Assembly in the Absence of Added Nucleotides
Shelanski, M. L., Gaskin, F., & Cantor, C. R. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.3.765 · Cited by 2,053
Microtubule Formation in vitro in Solutions Containing Low Calcium Concentrations
Weisenberg, R. C. (1972) · Science · doi:10.1126/science.177.4054.1104 · Cited by 1,210
Turbidimetric studies of the in vitro assembly and disassembly of porcine neurotubules
Gaskin, F., Cantor, C. R., & Shelanski, M. L. (1974) · Journal of Molecular Biology · doi:10.1016/0022-2836(74)90048-5 · Cited by 816
A theory of linear and helical aggregations of macromolecules
Oosawa, F., & Kasai, M. (1962) · Journal of Molecular Biology · doi:10.1016/s0022-2836(62)80112-0 · Cited by 766
Corliss, J. O., Inoue, S., & Stephens, R. E. (1977) · Transactions of the American Microscopical Society · doi:10.2307/3226119 · Cited by 763
Head to tail polymerization of actin
Wegner, A. (1976) · Journal of Molecular Biology · doi:10.1016/s0022-2836(76)80100-3 · Cited by 707
Opposite end assembly and disassembly of microtubules at steady state in vitro
Margolis, R. L., & Wilson, L. (1978) · Cell · doi:10.1016/0092-8674(78)90132-0 · Cited by 570
Research works printed but not linked: 3
- Schiff, P. B., Fant, J., Auster, L. A. & Horwitz, S. B. J. supramolec. Struct. 8, Suppl. 2, 328 (1978).
- Gaskin, F. & Shelanski, M. L. Essays Biochem. 12, 115–146 (1976).
- Borisy, G. G., Olmstead, J. B., Marcum, J. M. & Allen, C. Fedn Proc. 33, 167–174 (1974).
Cited by
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
“, underwent slow development until, in 1979, Peter Schiff and Susan Horwitz made the surprising discovery that, unlike the Vinca alkaloids, paclitaxel stimulated microtubule polymerizatio”
BackgroundDiscovery and resupply of pharmacologically active plant-derived natural products: A review
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., et al. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.08.001 · Cited by 2,904
“antimitotic agent that acted by promoting the irreversible assembly of tubulin into microtubules (Schiff et al., 1979; Schiff and Horwitz, 1980).”
BackgroundTaxol stabilizes microtubules in mouse fibroblast cells.
Schiff, P. B., & Horwitz, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1561 · Cited by 1,970
Self-citationRowinsky, E. K., & Donehower, R. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321507 · Cited by 1,924
Drug discovery from medicinal plants
Balunas, M. J., & Kinghorn, A. D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.09.012 · Cited by 1,810
“The taxanes, including paclitaxel and derivatives, act by binding tubulin without allowing depolymerization or interfering with tubulin assembly (Schiff et al., 1979; Horwitz, 2004).”
BackgroundMicrotubule-binding agents: a dynamic field of cancer therapeutics
Dumontet, C., & Jordan, M. A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3253 · Cited by 1,718
“and the taxanes, first isolated almost 40 years ag”
BackgroundTaxol and Taxane Production by Taxomyces andreanae , an Endophytic Fungus of Pacific Yew
Stierle, A., Strobel, G., & Stierle, D. (1993) · Science · doi:10.1126/science.8097061 · Cited by 1,701
How Taxol/paclitaxel kills cancer cells
Weaver, B. A. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-04-0916 · Cited by 1,547
“Furthermore, microtubules polymerized in the presence of paclitaxel are protected from the disassembly normally induced by cold or calcium treatment (Schiff et al., 1979).”
BackgroundStructural and Chemical Biology of Terpenoid Cyclases
Christianson, D. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00287 · Cited by 1,223
Hypersensitivity reactions from taxol.
Weiss, R. B., Donehower, R. C., Wiernik, P. H., Ohnuma, T., Gralla, R. J., Trump, D. L., Baker, J. R., Van Echo, D. A., Von Hoff, D. D., & Leyland-Jones, B. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1263 · Cited by 1,174
Nicolaou, K. C., Yang, Z., Liu, J. J., Ueno, H., Nantermet, P. G., Guy, R. K., Claiborne, C. F., Renaud, J., Couladouros, E. A., Paulvannan, K., et al. (1994) · Nature · doi:10.1038/367630a0 · Cited by 1,096
Paclitaxel and its formulations
Singla, A. K., Garg, A., & Aggarwal, D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00986-3 · Cited by 1,100
McGuire, W. P., Rowinsky, E. K., Rosenshein, N. B., Grumbine, F. C., Ettinger, D. S., Armstrong, D. K., & Donehower, R. C. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-4-273 · Cited by 1,100
Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.
Jordan, M. A., Toso, R. J., Thrower, D., & Wilson, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9552 · Cited by 1,095
The Methylation Effect in Medicinal Chemistry
Barreiro, E. J., Kümmerle, A. E., & Fraga, C. A. M. (2011) · Chemical Reviews · doi:10.1021/cr200060g · Cited by 1,017
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
Falzone, L., Salomone, S., & Libra, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01300 · Cited by 908
Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903
Post-translational regulation of the microtubule cytoskeleton: mechanisms and functions
Janke, C., & Chloë Bulinski, J. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3227 · Cited by 847
Axel, D. I., Kunert, W., Göggelmann, C., Oberhoff, M., Herdeg, C., Küttner, A., Wild, D. H., Brehm, B. R., Riessen, R., Köveker, G., et al. (1997) · Circulation · doi:10.1161/01.cir.96.2.636 · Cited by 784
Structural interaction of cytoskeletal components
Schliwa, M., & van Blerkom, J. (1981) · The Journal of Cell Biology · doi:10.1083/jcb.90.1.222 · Cited by 756
Rougier, P., Adenis, A., Ducreux, M., de Forni, M., Bonneterre, J., Dembak, M., Clouet, P., Lebecq, A., Baille, P., Lefresne-Soulas, F., et al. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00072-1 · Cited by 751
Band Horwitz, S. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90048-b · Cited by 740
Self-citationMechanisms of Taxol resistance related to microtubules
Orr, G. A., Verdier-Pinard, P., McDaid, H., & Horwitz, S. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206934 · Cited by 727
“…the mechanism of action of Taxol, and although it became obvious that the drug was an antimitotic agent, it was also clear that Taxol was not a typical antimitotic drug, such as colchicine or the vinca alkaloids (Schiff et al., 1979; Schiff and Horwitz, 1980; Horwitz et al., 1986; Horwitz, 1992).”
BackgroundSelf-citationViscoelastic properties of vimentin compared with other filamentous biopolymer networks.
Janmey, P. A., Euteneuer, U., Traub, P., & Schliwa, M. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.1.155 · Cited by 721
“…for each case is actin: 0.2% (0.1 ILM critical concentration [Stossel et al., 1985]); tubulin: 0.5% (0.01 mg/ml critical concentration in taxol [Schiff et al., 1979]); vimentin: <2.5% (0.05 nag/nil critical concentration [Steinert et ai., 1981]); and fibrin: <3% (based on measured clottability…”
BackgroundInfluentialAlbumin-bound paclitaxel: a next-generation taxane
Gradishar, W. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1041 · Cited by 712
“In addition, paclitaxel induces unusually stable tubulin complexes and abnormal arrays, or bundles, of microtubules throughout the cell cycle and multiple asters of microtubules that interfere with mitosis, resulting in cell death [4].”
BackgroundNanopharmaceuticals and Nanomedicines Currently on the Market: Challenges and Opportunities
Farjadian, F., Ghasemi, A., Gohari, O., Roointan, A., Karimi, M., & Hamblin, M. R. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0120 · Cited by 664
Natural products in cancer chemotherapy: past, present and future
Mann, J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc723 · Cited by 684
“Unlike vinblastine and vincristine, which destabilize microtubules, Taxol stabilizes them during cell divisio”
BackgroundAlbumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
Tomao, S. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s3061 · Cited by 695
Halogen Bonding: An Interim Discussion
Politzer, P., & Murray, J. S. (2013) · ChemPhysChem · doi:10.1002/cphc.201200799 · Cited by 689
Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.
Bollag, D. M., McQueney, P. A., Zhu, J., Hensens, O. D., Koupal, L. R., Liesch, J. M., Goetz, M., Lazarides, E., & Woods, C. M. (1995) · PubMed · Cited by 685
Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle
Jordan, A., Hadfield, J. A., Lawrence, N. J., & McGown, A. T. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199807)18:4<259::aid-med3>3.0.co;2-u · Cited by 673
Hirokawa, N. (1982) · The Journal of Cell Biology · doi:10.1083/jcb.94.1.129 · Cited by 671
“Taxol (39) is necessary to stabilize the MT in these extraction experiments, probably because the tubulin pool in the axoplasm has leaked out.”
BackgroundDomains of tau Protein and Interactions with Microtubules
Gustke, N., Trinczek, B., Biernat, J., Mandelkow, E.-M., & Mandelkow, E. (1994) · Biochemistry · doi:10.1021/bi00198a017 · Cited by 655
Filament organization revealed in platinum replicas of freeze-dried cytoskeletons.
Heuser, J. E., & Kirschner, M. W. (1980) · The Journal of cell biology · doi:10.1083/jcb.86.1.212 · Cited by 648
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
Danhier, F., Lecouturier, N., Vroman, B., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.086 · Cited by 616
“It disrupts the d ynamic equilibrium within the microtubule system and block s cells in the late G2 phase and M phase of the cel l cycle, thereby inhibiting cell replication [3].”
BackgroundTaxol binds to polymerized tubulin in vitro
Parness, J., & Horwitz, S. (1981) · The Journal of Cell Biology · doi:10.1083/jcb.91.2.479 · Cited by 620
“All other known effects of taxol on MTs in vitro have their maxima at concentrations approximately stoichiometric with the tubulin dimer concentration ( 2 , 4). It should be noted that measured maximal binding stoichiometries for drugs such as colchicine have been in the range of0.5-0.65 (22, 23, 24),and these values…”
BackgroundResultInfluentialSelf-citationChemistry and Biology of Taxol
Nicolaou, K. C., Dai, W., & Guy, R. K. (1994) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199400151 · Cited by 623
Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer
Abu Samaan, T. M., Samec, M., Liskova, A., Kubatka, P., & Büsselberg, D. (2019) · Biomolecules · doi:10.3390/biom9120789 · Cited by 569
“The drug reduces the critical concentration of tubulin required for its assembly, therefore promoting the lengthening of the tubulin polymer [65].”
BackgroundTaxol from Pestalotiopsis microspora, an endophytic fungus of Taxus wallachiana
Strobel, G., Yang, X., Sears, J., Kramer, R., Sidhu, R. S., & Hess, W. M. (1996) · Microbiology · doi:10.1099/13500872-142-2-435 · Cited by 593
Targeting Microtubules by Natural Agents for Cancer Therapy
Mukhtar, E., Adhami, V. M., & Mukhtar, H. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0791 · Cited by 565
Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy
Flatters, S. J. L., & Bennett, G. J. (2004) · Pain · doi:10.1016/j.pain.2004.01.029 · Cited by 576
“Paclitaxel promotes excessive tubulin polymerisation producing stable intracellular microtubules which interrupts mitosis, thus promoting apoptosis (Caplow et al., 1994; Haldar et al., 1997; Jordan et al., 1993; Schiff et al., 1979).”
BackgroundMacKeigan, J. P., Murphy, L. O., & Blenis, J. (2005) · Nature Cell Biology · doi:10.1038/ncb1258 · Cited by 561
“The chemotherapeutic agent Taxol induces apoptosis by binding and stabilizing microtubule”
BackgroundTaxol Suppresses Dynamics of Individual Microtubules in Living Human Tumor Cells
Yvon, A.-M. C., Wadsworth, P., & Jordan, M. A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.4.947 · Cited by 553
“High concentrations of taxol enhance microtubule polymerization and stabilize microtubules to depolymerization by cold temperature, calcium ions, dilution , and other antimitotic drugs such as vinblastine (Schiff et al., 1979; Kumar, 1981; Howard and Timasheff , 1988).”
BackgroundVallee, R. B. (1982) · The Journal of cell biology · doi:10.1083/jcb.92.2.435 · Cited by 551
Tau protein binds to microtubules through a flexible array of distributed weak sites.
Butner, K. A., & Kirschner, M. W. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.3.717 · Cited by 550
Gianni, L., Kearns, C. M., Giani, A., Capri, G., Viganó, L., Lacatelli, A., Bonadonna, G., & Egorin, M. J. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.180 · Cited by 553
Anticancer compounds derived from fungal endophytes: their importance and future challenges
Kharwar, R. N., Mishra, A., Gond, S. K., Stierle, A., & Stierle, D. (2011) · Natural Product Reports · doi:10.1039/c1np00008j · Cited by 530
Ann Jordan, M., Thrower, D., & Wilson, L. (1992) · Journal of Cell Science · doi:10.1242/jcs.102.3.401 · Cited by 531
nab-Paclitaxel mechanisms of action and delivery
Yardley, D. A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.041 · Cited by 508
Paclitaxel: a review of adverse toxicities and novel delivery strategies
Marupudi, N. I., Han, J. E., Li, K. W., Renard, V. M., Tyler, B. M., & Brem, H. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.5.609 · Cited by 510
“Paclitaxel is the prototype of a new class of chemotherapeutic agents [11] in which the assembly of microtubules is promoted and the disassembly inhibited via tubulin stabilization [12] , not destabilization.”
BackgroundInsulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons
Hong, M., & Lee, V. M.-Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19547 · Cited by 522
Kowalski, R. J., Giannakakou, P., & Hamel, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2534 · Cited by 511
Rabbani, G., & Ahn, S. N. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.11.053 · Cited by 505
Mechanisms of drug release in nanotherapeutic delivery systems
Wong, P. T., & Choi, S. K. (2015) · Chemical Reviews · doi:10.1021/cr5004634 · Cited by 507
Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents
Prota, A. E., Bargsten, K., Zurwerra, D., Field, J. J., Díaz, J. F., Altmann, K.-H., & Steinmetz, M. O. (2013) · Science · doi:10.1126/science.1230582 · Cited by 489
Taxol: an antimitotic agent with a new mechanism of action
Manfredi, J. J., & Horwitz, S. B. (1984) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(84)90025-1 · Cited by 483
Self-citationTubulin acetylation protects long-lived microtubules against mechanical ageing
Portran, D., Schaedel, L., Xu, Z., Théry, M., & Nachury, M. V. (2017) · Nature Cell Biology · doi:10.1038/ncb3481 · Cited by 491
“100 μM of acetyl Co-enzyme A (Sigma) was added for TAT1-mediated acetylation, and 1 mM NAD + (Sigma) was added for SIRT2-mediated deacetylation.”
InfluentialOrganization of mammalian neurofilament polypeptides within the neuronal cytoskeleton.
Hirokawa, N., Glicksman, M. A., & Willard, M. B. (1984) · The Journal of cell biology · doi:10.1083/jcb.98.4.1523 · Cited by 496
Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imaging
Jain, T. K., Richey, J., Strand, M., Leslie-Pelecky, D. L., Flask, C. A., & Labhasetwar, V. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.07.004 · Cited by 491
“These drugs work by different mechanisms: DOX acts via intercalation with DNA, [31] whereas PTX acts by interacting with microtubules [32,33].”
BackgroundMicrotubules, microtubule-interfering agents and apoptosis
Mollinedo, F., & Gajate, C. (2003) · Apoptosis · doi:10.1023/a:1025513106330 · Cited by 477
Peripheral Neuropathy Induced by Microtubule-Stabilizing Agents
Lee, J. J., & Swain, S. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.0543 · Cited by 472
“the taxanes and epothilones, stabilize microtubules, block mitosis, and induce cell death.(1,2) Taxanes in-”
BackgroundYukimune, Y., Tabata, H., Higashi, Y., & Hara, Y. (1996) · Nature Biotechnology · doi:10.1038/nbt0996-1129 · Cited by 474
Natural Product Drug Discovery in the Next Millennium
Cragg, G., & Newman, D. (2001) · Pharmaceutical Biology · doi:10.1076/phbi.39.7.8.5868 · Cited by 448
Taxol Biosynthesis and Molecular Genetics
Croteau, R., Ketchum, R. E. B., Long, R. M., Kaspera, R., & Wildung, M. R. (2006) · Phytochemistry Reviews · doi:10.1007/s11101-005-3748-2 · Cited by 459
“…1995; Rowinsky, 1997), the discovery of the novel mode of action of Taxol in binding b-tubulin to promote microtubule assembly and disrupt mitosis (Schiff et al., 1979) and, ultimately, the efforts of many clinical scientists in developing suitable formulations and treatment regimes (Adams et…”
BackgroundPhase I clinical and pharmacokinetic study of taxol.
Wiernik, P. H., Schwartz, E. L., Strauman, J. J., Dutcher, J. P., Lipton, R. B., & Paietta, E. M. (1987) · PubMed · Cited by 455
A Paclitaxel-Eluting Stent for the Prevention of Coronary Restenosis
Park, S.-J., Shim, W. H., Ho, D. S., Raizner, A. E., Park, S.-W., Hong, M.-K., Lee, C. W., Choi, D., Jang, Y., Lam, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021007 · Cited by 456
“(%) 1 2 3 4 32 (53) 20 (33) 8 (13) 0 36 (62) 17 (29) 4 (7) 1 (2) 39 (66) 15 (25) 5 (8) 0 107 (60) 52 (29) 17 (10) 1 (1)”
Clinical Pharmacokinetics of Docetaxel
Clarke, S. J., & Rivory, L. P. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936020-00002 · Cited by 446
“The taxanes are a novel class of anticancer drugs and act as promoters of microtubule polymerisation.[3] Tubulin is normally present in cells in a dynamic equilibrium between tubulin dimers and microtubules.”
Nepali, K., Sharma, S., Sharma, M., Bedi, P. M. S., & Dhar, K. L. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.018 · Cited by 435
Taxol and taxotere: discovery, chemistry, and structure-activity relationships
Guenard, D., Gueritte-Voegelein, F., & Potier, P. (1993) · Accounts of Chemical Research · doi:10.1021/ar00028a005 · Cited by 444
Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.
Shah, M. A., & Schwartz, G. K. (2001) · PubMed · Cited by 518
Cytotoxic studies of paclitaxel (Taxol®) in human tumour cell lines
Liebmann, J., Cook, J., Lipschultz, C., Teague, D., Fisher, J., & Mitchell, J. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.488 · Cited by 428
Total Synthesis of Baccatin III and Taxol
Danishefsky, S. J., Masters, J. J., Young, W. B., Link, J. T., Snyder, L. B., Magee, T. V., Jung, D. K., Isaacs, R. C. A., Bornmann, W. G., Alaimo, C. A., et al. (1996) · Journal of the American Chemical Society · doi:10.1021/ja952692a · Cited by 438
Medically Useful Plant Terpenoids: Biosynthesis, Occurrence, and Mechanism of Action
Bergman, M. E., Davis, B., & Phillips, M. A. (2019) · Molecules · doi:10.3390/molecules24213961 · Cited by 407
Pathological Analysis of Local Delivery of Paclitaxel Via a Polymer-Coated Stent
Farb, A., Heller, P. F., Shroff, S., Cheng, L., Kolodgie, F. D., Carter, A. J., Scott, D. S., Froehlich, J., & Virmani, R. (2001) · Circulation · doi:10.1161/hc3001.092037 · Cited by 423
Microtubule Organizing Centers
Brinkley, B. R. (1985) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.01.110185.001045 · Cited by 414
Diaz, J. F., & Andreu, J. M. (1993) · Biochemistry · doi:10.1021/bi00062a003 · Cited by 411
Paclitaxel: What has been done and the challenges remain ahead
Bernabeu, E., Cagel, M., Lagomarsino, E., Moretton, M., & Chiappetta, D. A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.016 · Cited by 413
Taxol: Mechanisms of Action and Resistancea
HORWITZ, S. B., LOTHSTEIN, L., MANFREDI, J. J., MELLADO, W., PARNESS, J., ROY, S. N., SCHIFF, P. B., SORBARA, L., & ZEHEB, R. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb38455.x · Cited by 416
Self-citationTaxol binds to cellular microtubules.
Manfredi, J. J., Parness, J., & Horwitz, S. B. (1982) · The Journal of cell biology · doi:10.1083/jcb.94.3.688 · Cited by 409
“Early work in our laboratory demonstrated that the drug inhibits replication of HeLa cells ( 47 ).”
BackgroundInfluentialSelf-citationZasadil, L. M., Andersen, K. A., Yeum, D., Rocque, G. B., Wilke, L. G., Tevaarwerk, A. J., Raines, R. T., Burkard, M. E., & Weaver, B. A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007965 · Cited by 402
“Unlike previously identified microtubule toxins, which result in microtubule depolymerization, paclitaxel promotes microtubule assembly and stabilization (3, 5, 9).”
Progress in adjuvant chemotherapy for breast cancer: an overview
Anampa, J., Makower, D., & Sparano, J. A. (2015) · BMC Medicine · doi:10.1186/s12916-015-0439-8 · Cited by 373
“Paclitaxel binds to microtubules and induces their stabilization by inhibiting their depolymerization, thereby leading to mitotic arrest [60, 61] and chromosome missegregation on abnormal multipolar spindles [62, 63].”
BackgroundTaxanes in cancer treatment: Activity, chemoresistance and its overcoming
Mosca, L., Ilari, A., Fazi, F., Assaraf, Y. G., & Colotti, G. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100742 · Cited by 385
Spencer, C. M., & Faulds, D. (1994) · Drugs · doi:10.2165/00003495-199448050-00009 · Cited by 396
Taxol-induced polymerization of purified tubulin. Mechanism of action.
Kumar, N. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68639-4 · Cited by 401
Synthesis of epothilones A and B in solid and solution phase
Nicolaou, K. C., Winssinger, N., Pastor, J., Ninkovic, S., Sarabia, F., He, Y., Vourloumis, D., Yang, Z., Li, T., Giannakakou, P., et al. (1997) · Nature · doi:10.1038/387268a0 · Cited by 400
A MAP kinase-dependent spindle assembly checkpoint in Xenopus egg extracts
Minshull, J., Sun, H., Tonks, N. K., & Murray, A. W. (1994) · Cell · doi:10.1016/0092-8674(94)90256-9 · Cited by 395
Structure of tubulin at 6.5 Å and location of the taxol-binding site
Nogales, E., Grayer Wolf, S., Khan, I. A., Ludueña, R. F., & Downing, K. H. (1995) · Nature · doi:10.1038/375424a0 · Cited by 389
Natural Products as a Resource for New Drugs
Clark, A. M. (1996) · Pharmaceutical Research · doi:10.1023/a:1016091631721 · Cited by 378
Taxol: the first of the taxanes, an important new class of antitumor agents.
Rowinsky, E. K., Onetto-Pothier, N., Canetta, R. M., & Arbuck, S. G. (1992) · PubMed · Cited by 389
De Brabander, M., Geuens, G., Nuydens, R., Willebrords, R., & De Mey, J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5608 · Cited by 387
Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
Kampan, N. C., Madondo, M. T., McNally, O. M., Quinn, M., & Plebanski, M. (2015) · BioMed Research International · doi:10.1155/2015/413076 · Cited by 362
“Paclitaxel also has the unique ability to promote microtubule formation in vitro even at cold temperatures (4∘C) and in the absence of GTP [46].”
BackgroundInfluentialMarkman, M., & Mekhail, T. M. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.6.755 · Cited by 375
“Unlike other antimicrotubular targeting agents, such as vinca alkaloids, which induce the disassembly of microtubules, paclitaxel promotes the polymerisation of tubulin [5,6,11-17].”
BackgroundUnpolymerized tubulin modulates the level of tubulin mRNAs
Cleveland, D. W., Lopata, M. A., Sherline, P., & Kirschner, M. W. (1981) · Cell · doi:10.1016/0092-8674(81)90072-6 · Cited by 393
Production of the anticancer drug taxol in Taxus baccata suspension cultures: A review
Malik, S., Cusidó, R. M., Mirjalili, M. H., Moyano, E., Palazón, J., & Bonfill, M. (2011) · Process Biochemistry · doi:10.1016/j.procbio.2010.09.004 · Cited by 374
Plant-based anticancer molecules: A chemical and biological profile of some important leads
Srivastava, V., Negi, A., Kumar, J. K., Gupta, M. M., & Khanuja, S. P. S. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.05.066 · Cited by 379
Thigpen, J. T., Blessing, J. A., Ball, H., Hummel, S. J., & Barrett, R. J. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.9.1748 · Cited by 372
Schiff, P. B., & Horwitz, S. B. (1981) · Biochemistry · doi:10.1021/bi00514a041 · Cited by 368
Self-citationParidaens, R., Biganzoli, L., Bruning, P., Klijn, J. G. M., Gamucci, T., Houston, S., Coleman, R., Schachter, J., Van Vreckem, A., Sylvester, R., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.724 · Cited by 364
Chen, S., Zhao, X., Chen, J., Chen, J., Kuznetsova, L., Wong, S. S., & Ojima, I. (2010) · Bioconjugate Chemistry · doi:10.1021/bc9005656 · Cited by 357
Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.
Rowinsky, E. K., Donehower, R. C., Jones, R. J., & Tucker, R. W. (1988) · PubMed · Cited by 368
Metadata
- Authors
- SCHIFF, P. B., FANT, J., & HORWITZ, S. B.
- Affiliations
- Albert Einstein College of Medicine (US)
- ORCID
- SCHIFF, PETER B.
- Venue
- Nature
- Published
- 1979-02
- Volume
- 277
- Issue
- 5698
- Pages
- 665-667
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2067299834
- Cited by
- 3,600
- References
- 18
- Citations by year
- 2026: 50 · 2025: 68 · 2024: 72 · 2023: 86 · 2022: 89 · 2021: 93 · 2020: 67 · 2019: 83 · 2018: 84 · 2017: 86 · 2016: 90 · 2015: 99 · 2014: 105 · 2013: 105 · 2012: 102
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- paclitaxel, microtubule assembly, tubulin, Taxus brevifolia, HeLa cells, cell cycle arrest, G2/M block, antitumour activity, colchicine, podophyllotoxin, microtubule depolymerization, critical concentration
- MeSH terms
- Animals, Antineoplastic Agents, Phytogenic, Calcium, Cattle, Cold Temperature, Glycoproteins, Kinetics, Microtubules, Molecular Weight, Protein Binding, Terpenes, Tubulin, Macromolecular Substances
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.